FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
Polyglutamine expansions in the ataxin-2 gene (ATXN2) cause autosomal dominant spinocerebellar ataxia type 2 (SCA2), but have recently also been associated with amyotrophic lateral sclerosis (ALS). We present clinical and pathological features of a family in which a pathological ATXN2 expansion led...
Main Authors: | Bäumer, D, East, S, Tseu, B, Zeman, A, Hilton, D, Talbot, K, Ansorge, O |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Towards a TDP-43-based biomarker for ALS and FTLD
by: Feneberg, E, et al.
Published: (2018) -
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01) -
Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
by: Yoshitaka Tamaki, et al.
Published: (2022-10-01) -
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01) -
ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes
by: Vieira de Sá, R, et al.
Published: (2024)